Statistics about Group B Streptococcal Infections


advertisement

About statistics: This page presents a variety of statistics about Group B Streptococcal Infections. The term 'prevalence' of Group B Streptococcal Infections usually refers to the estimated population of people who are managing Group B Streptococcal Infections at any given time. The term 'incidence' of Group B Streptococcal Infections refers to the annual diagnosis rate, or the number of new cases of Group B Streptococcal Infections diagnosed each year. Hence, these two statistics types can differ: a short-lived disease like flu can have high annual incidence but low prevalence, but a life-long disease like diabetes has a low annual incidence but high prevalence. For more information see about prevalence and incidence statistics.

Prevalence and incidence statistics for Group B Streptococcal Infections: (see also prevalence and incidence page for Group B Streptococcal Infections)
  Incidence (annual) of Group B Streptococcal Infections: 6.9 cases per 100,000 (DBMD)
  Incidence Rate: approx 1 in 14,492 or 0.01% or 18,767 people in USA [about data]
  Prevalance of Group B Streptococcal Infections: Group B streptococcus -- 6.9 cases per 100,000; estimated 18,900 cases and 1,900 deaths annually in the United States1 ... Approximately 19,000 cases occur annually in the United States; approximately 7,500 occurred in newborns before recent prevention. The rate of neonatal infection has decreased from 1.7 cases per 1,000 live births (1993) to 0.5 cases per 1,000 live births (2000).2
Death and mortality statistics for Group B Streptococcal Infections:
  Deaths from Group B Streptococcal Infections: 1,900 deaths annually in USA (DBMD)
  Deaths from Group B Streptococcal Infections: 1,900 deaths annually in the United States1
  Mortality rate: Approximately 20% of men and nonpregnant women with GBS disease die of the disease. 3
Society statistics for Group B Streptococcal Infections
  Costs for Group B Streptococcal Infections: $294 million annually in direct medical costs of neonatal disease before prevention (DBMD)
  Costs for Group B Streptococcal Infections: Direct medical costs of neonatal disease before prevention were $294 million annually. 2 '

Footnotes:
1. excerpt from Active Bacterial Core Surveillance: DBMD
2. excerpt from Group B Streptococcal Disease (GBS): DBMD
3. excerpt from Group B Streptococcal Disease (GBS) General: DBMD

Medical Tools & Articles:


Next articles:

Medical Articles:
 
 
CureResearch.comTM Copyright © 2010 Health Grades, Inc. All rights reserved.
Home | Contents | Search | Site Map | Feedback | Contact Us | Terms of Use | Privacy Policy | About Us | Advertise